About Darwin Platform Pharmaceuticals Limited
Data last updated:
Darwin Platform Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 03 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85191MH2012PLC235261. Its GSTIN is 27AAECD3888N1ZY (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Vasu Kumar and Rahul Jeewanlal Dhote.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.84 Cr. For the same year it recorded a net profit of ₹57.73 Lakh (net margin 2.2%) and EBITDA of ₹1.43 Cr (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 211% over three years and 163% over five years.
As per MCA filings, the company has open charges of ₹5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website darwinpharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH – Wing Unit No. 127 Ansa Industrial Estate Saki Vihar Road Saki Naka Andheri (Eas, T), Mumbai, Maharashtra, India – 400072
- IndustryHealthcare, Medical Consumables & Supplies
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Darwin Platform Pharmaceuticals Limited
The main business activity of Darwin Platform Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Darwin Platform Pharmaceuticals Limited
Darwin Platform Pharmaceuticals Limited is audited by JAIN ANIL & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAIN ANIL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Darwin Platform Pharmaceuticals Limited
Darwin Platform Pharmaceuticals has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Pincha Also directs: Darwin Platform Refineries Limited, Darwin Platform Industries Limited, Darwin Platform Infrastructure Limited and 5 more | Additional Director | 10 Oct 2023 | 2 Years 11 Months | Current |
| Vasu Kumar Also directs: Darwin Platform Capital Limited, Darwin Platform Logistics Limited, Darwin Platform Gold and Mining Limited and 5 more | Director | 11 Jun 2021 | 5 Years 3 Months | Current |
| Rahul Jeewanlal Dhote | Director | 05 Mar 2020 | 6 Years 7 Months | Current |
| Herambha Mukund Naik Also directs: Darwin Platform Industries Limited, Darwin Platform Gold and Mining Limited, Darwin Platform1 News Limited and 3 more | Director | 29 Sep 2015 | 11 Years 0 Months | Current |
Financials of Darwin Platform Pharmaceuticals Limited FY 2024 filings available
Darwin Platform Pharmaceuticals Limited reported revenue of ₹25.84 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR) of Darwin Platform Pharmaceuticals Limited
Revenue has grown at a compounded annual rate (CAGR) of 163% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Darwin Platform Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.43 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹57.73 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Darwin Platform Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Darwin Platform Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Darwin Platform Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Darwin Platform Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2023 | State Bank of India | ₹5 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Darwin Platform Pharmaceuticals Limited
Darwin Platform Pharmaceuticals Limited has a workforce of 0 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Darwin Platform Pharmaceuticals Limited
Darwin Platform Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECD3888N1ZY | Maharashtra | Active | 13 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Darwin Platform Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Darwin Platform Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Darwin Platform Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Darwin Platform Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Darwin Platform Pharmaceuticals Limited
Frequently Asked Questions about Darwin Platform Pharmaceuticals Limited
Darwin Platform Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 03 September 2012 (14+ years old) and is registered under CIN U85191MH2012PLC235261.
Darwin Platform Pharmaceuticals reported revenue of ₹25.84 Cr for FY 2024.
Darwin Platform Pharmaceuticals has 4 current directors:
- Manoj Pincha - Additional Director
- Vasu Kumar - Director
- Rahul Jeewanlal Dhote - Director
- Herambha Mukund Naik - Director
Darwin Platform Pharmaceuticals reported a net profit of ₹57.73 Lakh (net margin 2.2%) and EBITDA of ₹1.43 Cr (EBITDA margin 5.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Darwin Platform Pharmaceuticals is 211% over three years and 163% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Darwin Platform Pharmaceuticals is 27AAECD3888N1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Darwin Platform Pharmaceuticals is U85191MH2012PLC235261. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Darwin Platform Pharmaceuticals was incorporated on 03 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Darwin Platform Pharmaceuticals can be reached through the website darwinpharma.in. Its registered office is in Mumbai, Maharashtra, India.